Adenosine A2A Receptor Antagonists as Positron Emission Tomography (PET) Tracers

被引:0
作者
Khanapur, S. [1 ]
van Waarde, A. [1 ]
Ishiwata, K. [2 ]
Leenders, K. L. [4 ]
Dierckx, R. A. J. O. [1 ,3 ]
Elsinga, P. H. [1 ,3 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[2] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Tokyo, Japan
[3] Univ Hosp Ghent, Dept Nucl Med, Ghent, Belgium
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 GZ Groningen, Netherlands
关键词
Adenosine A(2A) receptor; Parkinson's disorder; positron emission tomography (PET); xanthine ligands; nonxanthine; ligands; SCH442416; TMSX; 6-OHDA PD model; MOVEMENT-DISORDER SOCIETY; CENTRAL-NERVOUS-SYSTEM; JOINT TASK-FORCE; PARKINSONS-DISEASE; THERAPEUTIC MANAGEMENT; PIPERAZINE DERIVATIVES; NEUROLOGICAL SOCIETIES; MEDICINAL CHEMISTRY; EUROPEAN FEDERATION; SELECTIVE LIGAND;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adenosine A(2A) receptor (A(2A)R) is highly concentrated in the striatum, and a therapeutic target for Parkinson's disorder (PD) and Huntington's disease. High affinity and selective radiolabeled A(2A)R antagonists can be important research and diagnostic tools for PD. Positron Emission Tomography (PET) can play an important role by measuring radiolabeled A(2A) antagonists non-invasively in the brain. However, till date no complete review on A(2A)R PET ligands is available. The present article has been therefore focused on available PET tracers for A(2A)R and their detailed biological evaluation in rodents, nonhuman primates and humans. Drug design and development by molecular modeling including new lead structures that are potential candidates for radiolabeling and mapping of cerebral A(2A)Rs is discussed in the present article. A brief overview of functions of adenosine in health and disease, including the relevance of A(2A)R for PD has also been presented.
引用
收藏
页码:312 / 328
页数:17
相关论文
共 118 条
[51]   The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist [J].
Jaakola, Veli-Pekka ;
Griffith, Mark T. ;
Hanson, Michael A. ;
Cherezov, Vadim ;
Chien, Ellen Y. T. ;
Lane, J. Robert ;
IJzerman, Adriaan P. ;
Stevens, Raymond C. .
SCIENCE, 2008, 322 (5905) :1211-1217
[52]   Adenosine receptors as therapeutic targets [J].
Jacobson, KA ;
Gao, ZG .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (03) :247-264
[53]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF 8-STYRYLXANTHINES AS A(2)-SELECTIVE ADENOSINE ANTAGONISTS [J].
JACOBSON, KA ;
GALLORODRIGUEZ, C ;
MELMAN, N ;
FISCHER, B ;
MAILLARD, M ;
VANBERGEN, A ;
VANGALEN, PJM ;
KARTON, Y .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) :1333-1342
[54]   Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations [J].
Jankovic, J .
MOVEMENT DISORDERS, 2005, 20 :S11-S16
[55]   Medical management of levodopa-associated motor complications in patients with Parkinson's disease [J].
Jankovic, Joseph ;
Stacy, Mark .
CNS DRUGS, 2007, 21 (08) :677-692
[56]   CHARACTERIZATION OF HUMAN STRIATAL A(2)-ADENOSINE RECEPTORS USING RADIOLIGAND BINDING AND PHOTOAFFINITY-LABELING [J].
JI, XD ;
STILES, GL ;
VANGALEN, PJM ;
JACOBSON, KA .
JOURNAL OF RECEPTOR RESEARCH, 1992, 12 (02) :149-169
[57]   Improved synthesis of [11C]SA4503, [11C]MPDX and [11C]TMSX by use of [11C]methyl triflate [J].
Kawamura, K ;
Ishiwata, K .
ANNALS OF NUCLEAR MEDICINE, 2004, 18 (02) :165-168
[58]   SITE-DIRECTED MUTAGENESIS IDENTIFIES RESIDUES INVOLVED IN LIGAND RECOGNITION IN THE HUMAN A(2A) ADENOSINE RECEPTOR [J].
KIM, JH ;
WESS, J ;
VANRHEE, AM ;
SCHONEBERG, T ;
JACOBSON, KA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :13987-13997
[59]   Molecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine scaffold [J].
Kumar, T. Santhosh ;
Mishra, Shilpi ;
Deflorian, Francesca ;
Yoo, Lena S. ;
Khai Phan ;
Kecskes, Miklos ;
Szabo, Angela ;
Shinkre, Bidhan ;
Gao, Zhan-Guo ;
Trenkle, William ;
Jacobson, Kenneth A. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (09) :2740-2745
[60]   Adenosine in tissue protection and tissue regeneration [J].
Linden, J .
MOLECULAR PHARMACOLOGY, 2005, 67 (05) :1385-1387